Related Experiment Video
Updated: May 18, 2026
08:48
Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Axonal transport and mitochondrial dysfunction in Alzheimer's disease
1Division of Cellular Biochemistry, University of Kaiserslautern, Kaiserslautern, Germany.
Neuro-Degenerative Diseases
|October 6, 2012
Summary
Alzheimer's disease (AD) involves neurodegeneration, not just plaque buildup. Soluble amyloid-beta and tau proteins may drive mitochondrial dysfunction and axonal transport issues, leading to neuron loss in AD.
Area of Science:
- Neuroscience
- Pathology
Background:
- Alzheimer's disease (AD) is the most common dementia, marked by amyloid plaques, neurofibrillary tangles, and neuron loss.
- Early AD pathology includes synaptic decline, axonal issues, mitochondrial hypometabolism, and oxidative stress.
Purpose of the Study:
- To review evidence supporting a hypothesis on AD pathogenesis.
- To propose a model for the interplay of AD pathological mechanisms.
Main Methods:
- Literature review and data synthesis.
- Hypothesis formulation based on current research.
Main Results:
- Non-aggregated amyloid-beta oligomers and specific phosphorylated tau species are implicated as key neurotoxic agents.
- These factors may initiate mitochondrial dysfunction, oxidative stress, and impaired axonal transport.
Conclusions:
- Oligomeric amyloid-beta and phosphorylated tau are proposed as primary drivers of neurodegeneration in AD.
- These mechanisms are hypothesized to be interconnected, leading to synaptic loss and neuronal death.
More Related Videos
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...